Literature DB >> 19954838

Gene delivery using a derivative of the protein transduction domain peptide, K-Antp.

Sang-Hyun Min1, Dong Min Kim, Mi Na Kim, Jiang Ge, Dong Chul Lee, In Young Park, Kyung Chan Park, Ji-Sook Hwang, Cheong-Weon Cho, Young Il Yeom.   

Abstract

Due to their intracellular permeability, protein transduction domains (PTDs) have been widely used to deliver proteins and peptides to mammalian cells. However, their performance in gene delivery has been relatively poor. To improve the efficiency of PTD-mediated gene delivery, we synthesized a new peptide, KALA-Antp (K-Antp), which contains the sequences for PTD of the third alpha-helix of Antennapedia (Antp) homeodomain and the fusogenic peptide KALA. In this configuration, Antp is designed to provide the cell permeation capacity and nuclear localization signal, while the KALA moiety to promote cellular entry of the peptide-DNA complex. An optimal K-Antp/DNA formula was nearly 400-600 fold more efficient than Antp or poly-lysine-Antp (L-Antp) in gene delivery, and comparable or superior to a commercial liposome. The K-Antp-mediated plasmid DNA transfection not only exhibited temperature sensitivity, reflecting the involvement of an endocytosis-mediated gene transfer mechanism similar to other known PTDs, but also temperature insensitivity, suggesting the role of an energy-independent mechanism. Incorporation of an endosomolytic polymer polyethylenimine (PEI) into the system or treatment with chloroquine further increased the efficiency of K-Antp-mediated gene delivery. These results demonstrate the potential of the combinatorial use of KALA, Antp and PEI in the development of efficient PTD-derived gene carriers. (c) 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19954838     DOI: 10.1016/j.biomaterials.2009.11.019

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  3 in total

1.  Diseases originate and terminate by genes: unraveling nonviral gene delivery.

Authors:  Rajan Swami; Indu Singh; Wahid Khan; Sistla Ramakrishna
Journal:  Drug Deliv Transl Res       Date:  2013-12       Impact factor: 4.617

Review 2.  Journey to the Center of the Cell: Current Nanocarrier Design Strategies Targeting Biopharmaceuticals to the Cytoplasm and Nucleus.

Authors:  Erik V Munsell; Nikki L Ross; Millicent O Sullivan
Journal:  Curr Pharm Des       Date:  2016       Impact factor: 3.116

3.  Highly effective antiangiogenesis via magnetic mesoporous silica-based siRNA vehicle targeting the VEGF gene for orthotopic ovarian cancer therapy.

Authors:  Yijie Chen; Xinran Wang; Ting Liu; Ding Sheng-Zi Zhang; Yunfei Wang; Hongchen Gu; Wen Di
Journal:  Int J Nanomedicine       Date:  2015-03-31
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.